JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1989; 13:665-672
© 1989 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grigg, L.
Right arrow Articles by Hunt, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grigg, L.
Right arrow Articles by Hunt, D

Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty

LE Grigg, TW Kay, PA Valentine, R Larkins, DJ Flower, EG Manolas, K O'Dea, AJ Sinclair, JL Hopper, and D Hunt

Department of Cardiology, Royal Melbourne Hospital, Victoria, Australia.

The effect of an eicosapentaenoic acid-rich encapsulated preparation of fish oil on the incidence of early restenosis after coronary angioplasty was assessed by a randomized double-blind placebo-controlled study. A total of 108 patients received either 10 capsules of fish oil (1.8 g eicosapentaenoic acid, 1.2 g docosahexaenoic acid) or 10 control capsules (50% olive oil, 50% corn oil), commencing the day before angioplasty and continuing for 4 months after angioplasty, in addition to treatment with aspirin and verapamil. In 101 (94%) of the 108 patients, follow-up angiographic or postmortem result was evaluated at a mean (+/- SD) of 100 (+/- 22) days. Angiographic restenosis was observed in 34% of patients (29% of lesions) in the fish oil-treated group and 33% of patients (31% of lesions) in the control group (no significant difference). The overall incidence of angiographic restenosis was significantly higher in patients with 1) recurrent angina pectoris, 2) a positive exercise test at follow-up after angioplasty, 3) residual stenosis greater than 30% immediately after angioplasty, and 4) dilation of the left anterior descending or right coronary artery. Biochemical investigations showed a greater decrease in the serum triglyceride levels in the fish oil-treated group versus the control group (p less than 0.05) but no differences between the two groups in cholesterol levels or platelet counts over the 4 month period. In conclusion, in this study, the administration of fish oil at a dose of 10 capsules/day did not reduce the incidence of early restenosis after coronary angioplasty.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
J. T. Willerson
Myocardial Revascularization with Cardiologic Interventional Devices
Card. Surg. Adult, January 1, 2003; 2(2003): 561 - 580.
[Full Text]


Home page
RadiologyHome page
M. Kalinowski, H. Alfke, S. Bergen, K. J. Klose, J. J. Barry, and H.-J. Wagner
Comparative Trial of Local Pharmacotherapy with L-Arginine, r-Hirudin, and Molsidomine to Reduce Restenosis after Balloon Angioplasty of Stenotic Rabbit Iliac Arteries
Radiology, June 1, 2001; 219(3): 716 - 723.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. J. Popma, E. M. Ohman, J. Weitz, A. M. Lincoff, R. A. Harrington, and P. Berger
Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
Chest, January 1, 2001; 119(1_suppl): 321S - 336S.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Faggin, M. Puato, A. Chiavegato, R. Franch, P. Pauletto, and S. Sartore
Fish Oil Supplementation Prevents Neointima Formation in Nonhypercholesterolemic Balloon-Injured Rabbit Carotid Artery by Reducing Medial and Adventitial Cell Activation
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 152 - 163.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
O. Johansen, M. Brekke, I. Seljeflot, M. Abdelnoor, and H. Arnesen
n-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study
J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1619 - 1626.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Mata, O. Varela, R. Alonso, C. Lahoz, M. de Oya, and L. Badimon
Monounsaturated and Polyunsaturated n-6 Fatty Acid–Enriched Diets Modify LDL Oxidation and Decrease Human Coronary Smooth Muscle Cell DNA Synthesis
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2088 - 2095.
[Abstract] [Full Text]


Home page
CirculationHome page
J. A. Cairns, J. Gill, B. Morton, R. Roberts, M. Gent, J. Hirsh, D. Holder, K. Finnie, J. F. Marquis, S. Naqvi, et al.
Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty: The EMPAR Study
Circulation, October 1, 1996; 94(7): 1553 - 1560.
[Abstract] [Full Text]


Home page
NEJMHome page
W. S. Weintraub, S. J. Boccuzzi, J. L. Klein, A. S. Kosinski, S. B. King, R. Ivanhoe, J. C. Cedarholm, M. E. Stillabower, J. D. Talley, S. J. DeMaio, et al.
Lack of Effect of Lovastatin on Restenosis after Coronary Angioplasty
N. Engl. J. Med., November 17, 1994; 331(20): 1331 - 1337.
[Abstract] [Full Text]


Home page
NEJMHome page
C. Landau, R. A. Lange, and L. D. Hillis
Percutaneous Transluminal Coronary Angioplasty
N. Engl. J. Med., April 7, 1994; 330(14): 981 - 993.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1989 by the American College of Cardiology Foundation.